Literature DB >> 25600987

Mitochondrial membrane disruption by aggregation products of ALS-causing superoxide dismutase-1 mutants.

Mohammad Salehi1, Maryam Nikkhah2, Atieh Ghasemi3, Seyed Shahriar Arab4.   

Abstract

More than 140 mutations in the SOD1 gene cause aggregation of the affected protein in familial forms of amyotrophic lateral sclerosis (fALS) which is a fatal progressive neurodegenerative disorder selectively affecting motor neurons. The causes of motor neuron death in ALS are poorly understood in general, but for fALS, aberrant oligomerization of SOD1 mutant proteins has been strongly concerned. Increasing evidences indicate that the interaction of amyloid aggregates with membranes is critical in the onset and progression of amyloid diseases. In spite of gathering reports describing mechanisms of membrane permeabilization by aggregates in model membranes, studies focused at characterizing the events occurring in biological membranes are exceptional. To gain insight into possible mechanisms of cytotoxicity at the membrane level, we describe interaction of the fibrillation products of the wild type (WT) and two mutants (E100K, D125H) of SOD1 obtained under destabilizing conditions with mitochondrial membranes. Release of mitochondrial enzymes, malate dehydrogenase (MDH) and adenylate kinase (AK), upon exposure to SOD1 aggregates demonstrates that these aggregates could affect membrane integrity. This effect correlates with the surface hydrophobicity of oligomers and their tendency toward amyloid formation, with the most toxic oligomers having high hydrophobicity and increased amount of amyloid formation.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Aggregation; Familial amyotrophic lateral sclerosis; Membrane permeability; Mitochondria; Superoxide dismutase

Mesh:

Substances:

Year:  2015        PMID: 25600987     DOI: 10.1016/j.ijbiomac.2015.01.022

Source DB:  PubMed          Journal:  Int J Biol Macromol        ISSN: 0141-8130            Impact factor:   6.953


  7 in total

1.  Repurposing carbamazepine for the treatment of amyotrophic lateral sclerosis in SOD1-G93A mouse model.

Authors:  Jing-Jing Zhang; Qin-Ming Zhou; Sheng Chen; Wei-Dong Le
Journal:  CNS Neurosci Ther       Date:  2018-04-14       Impact factor: 5.243

2.  Cryo-EM structure of an amyloid fibril formed by full-length human SOD1 reveals its conformational conversion.

Authors:  Li-Qiang Wang; Yeyang Ma; Han-Ye Yuan; Kun Zhao; Mu-Ya Zhang; Qiang Wang; Xi Huang; Wen-Chang Xu; Bin Dai; Jie Chen; Dan Li; Delin Zhang; Zhengzhi Wang; Liangyu Zou; Ping Yin; Cong Liu; Yi Liang
Journal:  Nat Commun       Date:  2022-06-17       Impact factor: 17.694

3.  Tyrosine Hydroxylase Binding to Phospholipid Membranes Prompts Its Amyloid Aggregation and Compromises Bilayer Integrity.

Authors:  Anne Baumann; Ana Jorge-Finnigan; Kunwar Jung-Kc; Alexander Sauter; Istvan Horvath; Ludmilla A Morozova-Roche; Aurora Martinez
Journal:  Sci Rep       Date:  2016-12-22       Impact factor: 4.379

4.  Simvastatin accelerated motoneurons death in SOD1G93A mice through inhibiting Rab7-mediated maturation of late autophagic vacuoles.

Authors:  Lin Bai; Yafei Wang; Jia Huo; Shuai Li; Ya Wen; Qi Liu; Jing Yang; Yaling Liu; Rui Li
Journal:  Cell Death Dis       Date:  2021-04-12       Impact factor: 8.469

5.  Etching of AuNPs Through Superoxide Radical Dismutation by Cu-Zn Superoxide Dismutase Resulted in Remarkable Changes of its Localized Surface Plasmon Resonance.

Authors:  Masoumeh Eghtedari; Samaneh Jafari Porzani; Masoud Javanmardi; Mohammad Reza Ganjali; Saman Hosseinkhani
Journal:  Iran J Biotechnol       Date:  2021-07-01       Impact factor: 1.671

6.  SOD-1 Variants in Amyotrophic Lateral Sclerosis: Systematic Re-Evaluation According to ACMG-AMP Guidelines.

Authors:  Paola Ruffo; Benedetta Perrone; Francesca Luisa Conforti
Journal:  Genes (Basel)       Date:  2022-03-18       Impact factor: 4.096

7.  ALS-linked misfolded SOD1 species have divergent impacts on mitochondria.

Authors:  Sarah Pickles; Sabrina Semmler; Helen R Broom; Laurie Destroismaisons; Laurine Legroux; Nathalie Arbour; Elizabeth Meiering; Neil R Cashman; Christine Vande Velde
Journal:  Acta Neuropathol Commun       Date:  2016-04-27       Impact factor: 7.801

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.